Rajwinder Lehal

Rajwinder Lehal

Company: Cellestia Biotech

Job title: Chief Executive Officer


NEW DATACase Study: CB-103 Mediated Inhibition of NOTCH Transcription Complex Causes an Expansion of Regulatory T Cells: Clinical Application for GvHD Prophylaxis & Beyond 5:15 pm

NOTCH signaling is well known for its role in immune modulation by regulating effector T cells and Treg cells. Clinical development of NOTCH inhibitors for autoimmune and inflammatory diseases impeded due to severe toxicities of these modalities Cellestia is developing a first-in-class NOTCH pathway inhibitor causes an expansion of Treg cells, inhibit activity of effector…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.